Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 2—February 2008

Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis

Asmaa Tazi*†‡, Thomas Gueudet§, Emanuelle Varon*, Liliane Gilly‡, Patrick Trieu-Cuot*¶, and Claire Poyart*†‡¶Comments to Author 
Author affiliations: *Assistance Publique-Hôpitaux de Paris, Paris, France; †Institut National de la Santé de la Recherche Médicale, Paris, France; ‡Université Paris Descartes, Paris, France; §Laboratoire Schuh-Biosphere, Strasbourg, France; ¶Institut Pasteur, Paris, France;

Main Article


MICs of fluoroquinolones for strains of group B streptococci (GBS), France

MIC (mg/L)*
GBS CNR07017 >64 >64 4 1 4 1
GBS NEM316 16 8 2 0.5 1 0.25

*Pef, pefloxacin; Nor, norfloxacin; Cip, ciprofloxacin; Spa, sparfloxacin; Lev, levofloxacin; Mox, moxifloxacin.

Main Article

Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.